13
Phase 2–4 trials
Cardiomyopathy & ATTR amyloidosis · Live ClinicalTrials.gov data
Tafamidis (Vyndaqel) clinical trial pipeline
ClinicalTrials.gov lists 13 phase 2–4 trials for tafamidis (Vyndaqel), 1 of them actively recruiting. Refreshed daily. Add up to four competitors to compare pipelines side by side.
5
Phase 3 trials
1
Actively recruiting
4,077
Participants across trials
Pfizer
Lead sponsor by trial count
tafamidis (13)3 active2007–2029
tafamidis
'07
'09
'11
'13
'15
'17
'19
'21
'23
'25
'27
'29
tafamidis
Safety and Efficacy Study of Fx-1006A in Patients With Familial AmyloidosisP2
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid PolyneuropathyP2
The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid CardiomyopathyP2
Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin AmyloidosisP3
The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M TransthyretinP3
ATTR-ACTP3
Long-term Safety of Tafamidis in Subjects With Transthyretin CardiomyopathyP3
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)P3
The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy PatientsP4
A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)P4
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTRP2
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart TransplantationP4
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid PolyneuropathyP4
Upcoming readouts
2 ahead · tafamidis
Select a trial to load its full ClinicalTrials.gov record.
Key tafamidis trials
Top 12 of the 13 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track tafamidis with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for tafamidis?
- ClinicalTrials.gov currently lists 13 phase 2–4 tafamidis trials: 4 phase 2, 5 phase 3, and 4 phase 4. 1 are actively recruiting.
- Are there clinical trials for Vyndaqel?
- Vyndaqel is the brand name for tafamidis, so tafamidis trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 13 phase 2–4 tafamidis trials: 4 phase 2, 5 phase 3, and 4 phase 4. 1 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare tafamidis against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.